Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$33.11 - $55.01 $416,854 - $692,575
-12,590 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$50.07 - $66.05 $13,018 - $17,173
-260 Reduced 2.02%
12,590 $630,000
Q2 2021

Jul 20, 2021

BUY
$56.61 - $80.46 $158,111 - $224,724
2,793 Added 27.77%
12,850 $809,000
Q1 2021

Apr 20, 2021

BUY
$86.23 - $125.19 $132,707 - $192,667
1,539 Added 18.07%
10,057 $934,000
Q4 2020

Jan 28, 2021

BUY
$79.17 - $111.47 $674,370 - $949,501
8,518 New
8,518 $763,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $416M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track First Business Financial Services, Inc. Portfolio

Follow First Business Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Business Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Business Financial Services, Inc. with notifications on news.